<DOC>
	<DOCNO>NCT01674959</DOCNO>
	<brief_summary>Radiation therapy plus concurrent chemotherapy demonstrate significant improvement overall disease-free survival accord Intergroup Trial 0116 patient gastric cancer surgical complete resection . Advantage application IMRT show plan comparison study postoperative gastric patient . So investigator design trial see safety efficacy postoperative concurrent chemoradiotherapy capecitabine combine IMRT stage II/II gastric cancer .</brief_summary>
	<brief_title>Postoperative IMRT Combined With Capecitabine Advanced Gastric Cancer Patients</brief_title>
	<detailed_description>In Intergroup 0116 , 64 % patient concurrent chemoradiation group complete treatment plan , recently report ARTIST trial , capecitabine admit concurrent radiotherapy , patient complete treatment planed concurrent group reach high 80 % . IMRT advance radiotherapy technology allow high conformal dose distribution Planing Tumor Volume ( PTV ) low dose organ risk . The purpose study evaluate feasibility efficacy concurrent IMRT combine capecitabine treatment gastric cancer patient D1/2 surgery .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . Postoperative histologically confirm advanced adenocarcinoma stomach gastroesophageal junction . 2 . Age 18 75 , Karnofsky score high 70 . 3 . Postoperative histologically conform metastasis perigastric lymph node and/or tumor invasion muscularis propria subserosa , without positive incisal margin . Stage II/III ( AJCC 7th ) . 4 . No severe functional damage major organ , normal blood cell , normal liver kidney function . 5 . No clinical finding distant metastasis . 6 . Predictive survival time longer 6 month . 1 . Peritoneal carcinomatosis , diagnose mandatory laparoscopy distant metastasis 2 . Concurrent treatment experimental drug anticancer therapy , treatment within clinical trial within 30 day prior trial entry 3 . Severe uncontrolled cardiovascular disease ( congestive heart failure NYHA III IV , myocardial infarction within last 12 month , unstable angina pectoris , significant arrhythmia ) 4 . Active uncontrolled infection . 5 . Definitive contraindication use corticosteroid premedication 6 . Prior systemic ( chemo target ) treatment . Prior radiotherapy upper abdomen 7 . Any contraindication treatment cetuximab , capecitabine cisplatin 8 . Previous malignancy within 5 year , exception adequately treat cervical carcinoma situ localize nonmelanoma skin cancer 9 . Known hypersensitivity study drug ( capecitabine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>radiation</keyword>
	<keyword>chemotherapy</keyword>
</DOC>